234 related articles for article (PubMed ID: 24265728)
1. The central role of AMP-kinase and energy homeostasis impairment in Alzheimer's disease: a multifactor network analysis.
Caberlotto L; Lauria M; Nguyen TP; Scotti M
PLoS One; 2013; 8(11):e78919. PubMed ID: 24265728
[TBL] [Abstract][Full Text] [Related]
2. Genomic convergence and network analysis approach to identify candidate genes in Alzheimer's disease.
Talwar P; Silla Y; Grover S; Gupta M; Agarwal R; Kushwaha S; Kukreti R
BMC Genomics; 2014 Mar; 15(1):199. PubMed ID: 24628925
[TBL] [Abstract][Full Text] [Related]
3. Integrative network analysis of nineteen brain regions identifies molecular signatures and networks underlying selective regional vulnerability to Alzheimer's disease.
Wang M; Roussos P; McKenzie A; Zhou X; Kajiwara Y; Brennand KJ; De Luca GC; Crary JF; Casaccia P; Buxbaum JD; Ehrlich M; Gandy S; Goate A; Katsel P; Schadt E; Haroutunian V; Zhang B
Genome Med; 2016 Nov; 8(1):104. PubMed ID: 27799057
[TBL] [Abstract][Full Text] [Related]
4. Functional annotation of Alzheimer's disease associated loci revealed by GWASs.
Han Z; Huang H; Gao Y; Huang Q
PLoS One; 2017; 12(6):e0179677. PubMed ID: 28650998
[TBL] [Abstract][Full Text] [Related]
5. Analyzing the genes related to Alzheimer's disease via a network and pathway-based approach.
Hu YS; Xin J; Hu Y; Zhang L; Wang J
Alzheimers Res Ther; 2017 Apr; 9(1):29. PubMed ID: 28446202
[TBL] [Abstract][Full Text] [Related]
6. Network pharmacology-based strategy to investigate pharmacological mechanisms of Tinospora sinensis for treatment of Alzheimer's disease.
Zhou F; He K; Guan Y; Yang X; Chen Y; Sun M; Qiu X; Yan F; Huang H; Yao L; Liu B; Huang L
J Ethnopharmacol; 2020 Sep; 259():112940. PubMed ID: 32389853
[TBL] [Abstract][Full Text] [Related]
7. Potential hippocampal genes and pathways involved in Alzheimer's disease: a bioinformatic analysis.
Zhang L; Guo XQ; Chu JF; Zhang X; Yan ZR; Li YZ
Genet Mol Res; 2015 Jun; 14(2):7218-32. PubMed ID: 26125932
[TBL] [Abstract][Full Text] [Related]
8. The Triangle of Death in Alzheimer's Disease Brain: The Aberrant Cross-Talk Among Energy Metabolism, Mammalian Target of Rapamycin Signaling, and Protein Homeostasis Revealed by Redox Proteomics.
Di Domenico F; Barone E; Perluigi M; Butterfield DA
Antioxid Redox Signal; 2017 Mar; 26(8):364-387. PubMed ID: 27626216
[TBL] [Abstract][Full Text] [Related]
9. The molecular bases of Alzheimer's disease and other neurodegenerative disorders.
Maccioni RB; Muñoz JP; Barbeito L
Arch Med Res; 2001; 32(5):367-81. PubMed ID: 11578751
[TBL] [Abstract][Full Text] [Related]
10. Deciphering molecular bridges: Unveiling the interplay between metabolic syndrome and Alzheimer's disease through a systems biology approach and drug repurposing.
Azizan Z; Zali H; Mirmotalebisohi SA; Bazrgar M; Ahmadiani A
PLoS One; 2024; 19(5):e0304410. PubMed ID: 38809924
[TBL] [Abstract][Full Text] [Related]
11. Sharing of Genetic Association Signals by Age-Related Macular Degeneration and Alzheimer's Disease at Multiple Levels.
Tan H; Lv M; Tan X; Su G; Chang R; Yang P
Mol Neurobiol; 2020 Nov; 57(11):4488-4499. PubMed ID: 32748369
[TBL] [Abstract][Full Text] [Related]
12. Gene expression and functional annotation of human choroid plexus epithelium failure in Alzheimer's disease.
Bergen AA; Kaing S; ten Brink JB; ; Gorgels TG; Janssen SF
BMC Genomics; 2015 Nov; 16():956. PubMed ID: 26573292
[TBL] [Abstract][Full Text] [Related]
13. Integrating network, sequence and functional features using machine learning approaches towards identification of novel Alzheimer genes.
Jamal S; Goyal S; Shanker A; Grover A
BMC Genomics; 2016 Oct; 17(1):807. PubMed ID: 27756223
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic Potential of AMP-Activated Protein Kinase in Alzheimer's Disease.
Wang X; Zimmermann HR; Ma T
J Alzheimers Dis; 2019; 68(1):33-38. PubMed ID: 30776001
[TBL] [Abstract][Full Text] [Related]
15. In Silico Analyses for Key Genes and Molecular Genetic Mechanism in Epilepsy and Alzheimer's Disease.
Jiang XW; Lu HY; Xu Z; Liu TY; Wu Q; Yang Y; Zhao QC; Gao HY
CNS Neurol Disord Drug Targets; 2018; 17(8):608-617. PubMed ID: 30047339
[TBL] [Abstract][Full Text] [Related]
16. Related Network and Differential Expression Analyses Identify Nuclear Genes and Pathways in the Hippocampus of Alzheimer Disease.
Quan X; Liang H; Chen Y; Qin Q; Wei Y; Liang Z
Med Sci Monit; 2020 Jan; 26():e919311. PubMed ID: 31989994
[TBL] [Abstract][Full Text] [Related]
17. miR-590-3 and SP1 Promote Neuronal Apoptosis in Patients with Alzheimer's Disease via AMPK Signaling Pathway.
Cao Y; Tan X; Lu Q; Huang K; Tang X; He Z
Contrast Media Mol Imaging; 2021; 2021():6010362. PubMed ID: 34992508
[TBL] [Abstract][Full Text] [Related]
18. A combined molecular biology and network pharmacology approach to investigate the multi-target mechanisms of Chaihu Shugan San on Alzheimer's disease.
Zeng Q; Li L; Siu W; Jin Y; Cao M; Li W; Chen J; Cong W; Ma M; Chen K; Wu Z
Biomed Pharmacother; 2019 Dec; 120():109370. PubMed ID: 31563815
[TBL] [Abstract][Full Text] [Related]
19. Condition-specific gene co-expression network mining identifies key pathways and regulators in the brain tissue of Alzheimer's disease patients.
Xiang S; Huang Z; Wang T; Han Z; Yu CY; Ni D; Huang K; Zhang J
BMC Med Genomics; 2018 Dec; 11(Suppl 6):115. PubMed ID: 30598117
[TBL] [Abstract][Full Text] [Related]
20. Genome-wide Network-assisted Association and Enrichment Study of Amyloid Imaging Phenotype in Alzheimer's Disease.
Li J; Chen F; Zhang Q; Meng X; Yao X; Risacher SL; Yan J; Saykin AJ; Liang H; Shen L;
Curr Alzheimer Res; 2019; 16(13):1163-1174. PubMed ID: 31755389
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
